KitoZyme

Home › Products & Solutions › Specialty Ingredients › Medical pharma
Print this page
 

Specialty Ingredients

Medical pharma

The ultra-pure animal-free chitosan

Medical pharma

In a radical break with the past, KitoZyme can offer medical devices and pharmaceutical professionals in the field of human and animal health a range of biopolymers based on chitosan of non-animal origin which is ultra-pure, reproducible, traceable, hypoallergenic and competitively priced - in other words, ideal for applications in which pure and ultra-pure chitosans yield top results.

KitoZyme injects the right solution into your business with its ultra-pure GMP biopolymers range called KiOmedine®.

Partnering with KitoZyme and injecting KiOmedine® technology into your pharmaceutical or medical devices business will give you the competitive edge you need by:

Injecting pioneering developments into your business

Cut short the lead time between proof-of-concept, pilot study and full market launch by relying on KitoZyme’s expertise. With the help of our huge know-how and our strong customer support, your development work will land right on time with no surprises allowing you to stay ahead of the competition.

Researching

KitoZyme's technology enables a tight management of the molecular characteristics of chitosan, and to offer a range of 4 different molecular weight of ultra-pure GMP chitosan.

The KiOmedine®range is now distributed by Sigma-Aldrich for research purposes. Click here to order samples and find detailed information : Sigma-Aldrich website

Injecting innovation into your R&D

If your R&D needs efficient biopolymers then KiOmedine® is right for you. Thanks to the reliable supply of our ultra-pure non-animal sourced chitosan with high safety profile and our skilled researcher’s expertise, you will safely fast-track your projects.

Ultra-pure animal-free GMP chitosan

KiOmedine® is a pioneering platform of ultra-pure biopolymers for therapeutic innovations.

KiOmedine® offers you unique features:

  • Wide range of top performances & functionalities
  • Easiness of screening
  • 100% animal-free
  • High purity and safety profile: Low bioburden, Endotoxin-free
  • Outstanding traceability
  • Strong documentation
  • Produced according to a fully validated cGMP process, in KitoZyme’s ISO7/ISO8 facilities in Europe.

Safe and reliable KiOmedine®’s GMP biopolymers are ideal for:

  • Wound healing and hemostasis
  • Biosurgery and Ophtalmology
  • Scaffold and cell therapy
  • Drug delivery and vaccines

KitoZyme offers…

KiOmedine®-CsU

KitoZyme has designed KiOmedine®-Csu suitable for all use including injectables and implantables.

KiOmedine-CsU® is world’s first ultra-pure chitosan, produced from a non-animal source, in accordance with a cGMP patented process in KitoZyme’s ISO7/ISO8 facilities. A recent development in its technology has enabled the production of a larger molecular weight biopolymer, thereby broadening the KiOmedine-CsU® range and giving access to new functionalities of the biopolymer for therapeutic innovation. These new features are immensely beneficial when high mechanical properties, high viscosity at a lower concentration and fast degradation rates are sought.

The average molecular weight of KiOmedine-CsU® is now in the range of 30,000 to 200,000, with narrow polydispersity and high batch-to-batch consistency. This extended range gives the opportunity to medical and pharmaceutical companies to screen variable molecular characteristics for optimum and consistent performance, providing opportunities for customized specification and greater differentiation of the final formulations.

KiOmedine®-T

KitoZyme has designed KiOmedine®-T suitable for topical and oral care(high chitosan content, highly controlled microbial burden).